DS-7113b phase II study
Phase 2
- Conditions
- Moderate to severe cancer pain
- Registration Number
- JPRN-jRCT2080222120
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with cancer pain whose pain is controlled by steady dose of an oral morphine during the screening period.
-Patients whose frequency of rescue dose during the screening period is within the specified number.
-Patients with an ECOG PS of =<3, etc.
Exclusion Criteria
Patients with symptom(s)/finding(s) falling under the contraindications or relative contraindications stated in the package insert of oral morphine preparations, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain control achievement rates
- Secondary Outcome Measures
Name Time Method Efficacy rate at completion of study treatment, efficacy and safety